Cellebrite Announces Warrant Redemption Fair Market Value

Ticker: CLBT · Form: 6-K · Filed: Aug 30, 2024 · CIK: 1854587

Cellebrite Di Ltd. 6-K Filing Summary
FieldDetail
CompanyCellebrite Di Ltd. (CLBT)
Form Type6-K
Filed DateAug 30, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.10
Sentimentneutral

Sentiment: neutral

Topics: warrants, redemption, announcement

TL;DR

Cellebrite announced the fair market value for its public warrants ahead of their redemption.

AI Summary

On August 30, 2024, Cellebrite DI Ltd. announced the "Redemption Fair Market Value" for its outstanding public warrants. This announcement is in connection with the company's previously disclosed redemption of all its public warrants to purchase ordinary shares.

Why It Matters

This filing provides crucial information for warrant holders regarding the value of their warrants in relation to an upcoming redemption, impacting their investment decisions.

Risk Assessment

Risk Level: low — The filing is an informational announcement regarding a previously disclosed event and does not introduce new financial risks.

Key Players & Entities

  • Cellebrite DI Ltd. (company) — Registrant
  • August 30, 2024 (date) — Announcement Date
  • Public Warrants (security) — Instrument subject to redemption

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K filing is to announce the "Redemption Fair Market Value" in connection with Cellebrite DI Ltd.'s previously announced redemption of all its outstanding public warrants.

When was the announcement made?

The announcement regarding the "Redemption Fair Market Value" was made on August 30, 2024.

What specific securities are being redeemed?

The company is redeeming all of its outstanding public warrants to purchase ordinary shares of the Company.

What is the company's principal executive office address?

The company's principal executive office is located at 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel.

Does Cellebrite file annual reports under Form 20-F or 40-F?

Cellebrite DI Ltd. files annual reports under Form 20-F.

Filing Stats: 524 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2024-08-30 08:12:37

Key Financial Figures

  • $0.10 — in each case for a redemption price of $0.10 per Warrant. The Public Warrants were

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellebrite DI Ltd. August 30, 2024 By: /s/ Dana Gerner Dana Gerner Chief Financial Officer 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.